| 17-Hydroxyprogesterone Caproate | Placebo |
---|---|---|
 | (N = 4) | (N = 8) |
Primary Outcome | ||
   Delivery at 34.0 weeks or more | 0 | 0 |
   Delivery at 32.0-33.9 weeks with documented fetal lung maturity | 0 | 0 |
Gestational Age at Delivery (weeks) | 30 ± 4 | 28 ± 3 |
Delivery before 32 weeks | 2 (50%) | 7 (87.5%) |
Delivery before 34 weeks | 4 (100%) | 8 (100%) |
Pulmonary Maturity Testing | ||
   Immature | 1 (25%) | 2 (25%) |
   Not Tested | 3 (75%) | 6 (75%) |
Latency, Randomization to Delivery (weeks) | 1.6 ± 1.0 | 1.3 ± 1.6 |
   Less than 1 week | 1 (25%) | 5 (62.5%) |
   1.0 to 1.9 weeks | 1 (25%) | 1 (12.5%) |
   2.0 weeks or more | 2 (50%) | 2 (25%) |
Reason for Delivery Before 34 weeks | ||
   Spontaneous | 0 | 4 (25%) |
   Chorioamnionitis | 1 (25%) | 2 (25%) |
   Fetal Indications | 3 (75%) | 2 (25%) |